| Indole–a promising pharmacophore in recent antiviral drug discovery A Dorababu RSC Medicinal Chemistry 11 (12), 1335-1353, 2020 | 106 | 2020 |
| Recent update on antibacterial and antifungal activity of quinoline scaffolds A Dorababu Archiv der Pharmazie 354 (3), 2000232, 2021 | 71 | 2021 |
| Synthesis, characterization and in vitro anticancer evaluation of novel 1, 2, 4-triazolin-3-one derivatives PP Kattimani, RR Kamble, MY Kariduraganavar, A Dorababu, RK Hunnur European Journal of Medicinal Chemistry 62, 232-240, 2013 | 53 | 2013 |
| Quinoline: A promising scaffold in recent antiprotozoal drug discovery A Dorababu ChemistrySelect 6 (9), 2164-2177, 2021 | 38 | 2021 |
| Identification of quinoline-chalcones and heterocyclic chalcone-appended quinolines as broad-spectrum pharmacological agents D Atukuri, S Vijayalaxmi, R Sanjeevamurthy, L Vidya, R Prasannakumar, ... Bioorganic Chemistry 105, 104419, 2020 | 33 | 2020 |
| Critical evaluation of current Alzheimer’s drug discovery (2018–19) & futuristic Alzheimer drug model approach A Dorababu Bioorganic Chemistry 93, 103299, 2019 | 29 | 2019 |
| Coumarin-heterocycle framework: A privileged approach in promising anticancer drug design A Dorababu European Journal of Medicinal Chemistry Reports 2, 100006, 2021 | 28 | 2021 |
| Report on recently (2017–20) designed quinoline‐based human cancer cell growth inhibitors A Dorababu ChemistrySelect 5 (44), 13902-13915, 2020 | 26 | 2020 |
| Synthesis of sydnone substituted Biginelli derivatives as hyaluronidase inhibitors T Gireesh, RR Kamble, PP Kattimani, A Dorababu, M Manikantha, ... Archiv der Pharmazie 346 (9), 645-653, 2013 | 25 | 2013 |
| Promising heterocycle-based scaffolds in recent (2019–2021) anti-Alzheimer's drug design and discovery A Dorababu European Journal of Pharmacology 920, 174847, 2022 | 24 | 2022 |
| C5‐Alkyl‐1,3,4‐Oxadiazol‐2‐ones Undergo Dealkylation upon Nitrogen Insertion to Form 2H‐1,2,4‐Triazol‐3‐ones: Synthesis of 1,2,4‐Triazol‐3‐one Hybrids … PP Kattimani, RR Kamble, A Dorababu, RK Hunnur, AA Kamble, ... Journal of Heterocyclic Chemistry 54 (4), 2258-2265, 2017 | 21 | 2017 |
| Pharmacological report of recently designed multifunctional coumarin and coumarin–heterocycle derivatives A Dorababu Archiv der Pharmazie 355 (2), 2100345, 2022 | 20 | 2022 |
| Contribution of N‐heterocycles towards anti‐tubercular drug discovery (2014–2019); predicted and reengineered molecular frameworks D Atukuri, R Gunjal, N Holagundi, B Korlahalli, S Gangannavar, ... Drug Development Research 82 (6), 767-783, 2021 | 20 | 2021 |
| Pyrazolopyridine: An efficient pharmacophore in recent drug design and development D Atukuri Chemical Biology & Drug Design 100 (3), 376-388, 2022 | 19 | 2022 |
| Synthesis, pharmacological evaluation and structure-activity relationship of recently discovered enzyme antagonist azoles A Dorababu Heliyon 6 (4), 2020 | 14 | 2020 |
| TiCl4: An efficient catalyst for one-pot synthesis of 1, 2-dihydro-1-aryl-naphtho-[1, 2-e][1, 3] oxazin-3-one derivatives and their drug score analysis R Hunnur, R Kamble, A Dorababu, BS Kumar, C Bathula Arabian Journal of Chemistry 10, S1760-S1764, 2017 | 14 | 2017 |
| Mg (ClO 4) 2 catalyzed Eco-benign synthesis of 1, 2, 4-triazolinone derivatives as anti-tubercular agents D Atukuri, P Kattimani, R Kamble Organic communications 4 (4), 94, 2011 | 13 | 2011 |
| Synthesis of Novel 1, 2, 4‐Triazole Derivatives as Antimicrobial Agents via the Japp‐Klingemann Reaction: Investigation of Antimicrobial Activities T Taj, RR Kamble, A Dorababu, GY Meti Journal of Chemistry 2013 (1), 909706, 2013 | 8 | 2013 |
| Update of recently (2016–2020) designed azepine analogs and related heterocyclic compounds with potent pharmacological activities A Dorababu Polycyclic Aromatic Compounds 43 (3), 2250-2268, 2023 | 7 | 2023 |
| Pyrazolopyrimidines as attractive pharmacophores in efficient drug design: A recent update A Dorababu Archiv der Pharmazie 355 (10), 2200154, 2022 | 7 | 2022 |
